Skip to main content
Explore URMC

Richard Dunne, M.D., M.S.

Contact Information

Phone Numbers

Appointment: (585) 275-8762

Fax: (585) 273-1051

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting



When a patient is diagnosed with cancer, he or she is faced with a lot of questions and uncertainty of what the future holds. My philosophy is to provide as much information as possible so that patients can make the best decisions for themselves and their families and so that together we can face any fears or worries head on.

I chose this field because my hope is to make the lives of cancer patients better – whether it is through direct patient care or my research, which focuses on pancreatobiliary cancers, as well as weight loss and muscle wasting related to cancer.

In addition to being passionate about cancer care, I have many interests outside of work that I enjoy sharing with my patients such as sports, travel and music.

Conditions I Treat

- Esophageal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer
- Colorectal cancer
- Anal cancer




    MD | SUNY Downstate Health Sciences University - College of Medicine

    MS | University of Rochester

    Post-doctoral Training & Residency

    07/01/2016 - 06/30/2019
    Fellowship at University of Rochester Medical Center

    07/01/2013 - 06/30/2015
    Fellowship in Hematology & Oncology at University of Rochester Medical Center

    06/25/2010 - 06/24/2012
    Residency in Internal Medicine at University of Rochester Medical Center

    06/25/2009 - 06/24/2010
    Internship in Internal Medicine at University of Rochester Medical Center

    VIEW ALL expand_more


    2022 - 2027
    Cancer Grand Challenges: Understand and Reverse Cachexia
    Sponsor: National Cancer Institute and Cancer Research UK

    2019 - 2021
    CTSI KL2 Career Development Award
    Location: University of Rochester Medical Center

    2017 - 2018
    Department of Medicine Research Pilot Grant Award

    2016 - 2019
    NIH R25 Fellowship Training Program in Cancer Control
    Location: University of Rochester Medical Center

    2015 - 2018
    Wilmot Foundation for Cancer Research Fellowship Award

    VIEW ALL expand_more

    Clinical Trials

    UGIM-16011: Evaluating the Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in patients with Cancer of the Upper Gastrointestinal Tract with Pre-cachexia or Cachexia: A Pilot Study

    Lead Researcher: Richard F Dunne

    We would also like to find out if this exercise intervention improves physical performance, day-to-day function, quality of life, and how the exercise may affect markers of inflammation in the blood over time. Cancer cachexia is a complex condition that can result in weight loss, muscle weakness, and/or tiredness, and may affect your normal daily activities and quality of life. Cachexia is common in patients with upper gastrointestinal tract cancers (esophageal, stomach, bile duct or liver cancer, and pancreatic cancer). There is little information on how these symptoms may develop or change as cachexia progresses, or how exercise may help improve these symptoms. Currently more information is needed on how physical performance and quality of life is affected by cachexia. There are no drugs approved for cachexia so understanding cachexia and its effect on the body may guide the development of interventions to help other patients with cancer cachexia.

    View Study Details


    Journal Articles

    Melucci AD, Lynch OF, Loria A, Mustian KM, Dunne RF, Temple LK, Fleming FJ. "A Novel Use for Pelvic Magnetic Resonance Imaging Scans to Estimate Lean Body Mass and Screen for Sarcopenia in Patients with Rectal Cancer." Diseases of the colon and rectum.. 2022 Dec 22; Epub 2022 Dec 22.

    Williams HL, Dias Costa A, Zhang J, Raghavan S, Winter PS, Kapner KS, Ginebaugh SP, Väyrynen SA, Väyrynen JP, Yuan C, Navia AW, Wang J, Yang A, Bosse TL, Kalekar RL, Lowder KE, Lau MC, Elganainy D, Morales-Oyarvide V, Rubinson DA, Singh H, Perez K, Cleary JM, Clancy TE, Wang J, Mancias JD, Brais LK, Hill ER, Kozak MM, Linehan DC, Dunne RF, Chang DT, Koong AC, Hezel AF, Hahn WC, Shalek AK, Aguirre AJ, Nowak JA, Wolpin BM. "Spatially-resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intra-tumoral heterogeneity." Cancer research.. 2022 Dec 2; Epub 2022 Dec 02.

    Loria A, Glance LG, Melucci AD, Boodry C, Justiniano CF, Dunne RF, Mustian KM, Becerra AZ, Jusko TA, Temple LK, Fleming FJ. "Low Preoperative Serum Creatinine is Common and Associated with Poor outcomes following Non-emergent Inpatient Surgery." Annals of surgery.. 2022 Nov 28; Epub 2022 Nov 28.